Ispire Collaborates with Berify and Chemular on Blockchain Technology

Business by { "type": "", "title": "", "logo": "", "description": "", "auth": "", "seo_url": "" }

Feb.23.2024

Ispire Collaborates with Berify and Chemular on Blockchain Technology

Ispire collaborates with Touchpoint World Wide Inc. and Chemular International Inc. to accelerate e-cigarette technology innovation in a new venture.

According to a report by UPI on February 22nd, Ispire (ISPIRE) has announced a partnership with Touchpoint World Wide Inc. (Berify, a platform specializing in linking physical products to the digital world, digital engagement, and brand protection) and Chemular International Inc to establish a joint venture.

This joint venture will focus on accelerating innovation in the e-cigarette technology sector, including the development of safe, user-friendly age verification and age restriction vaporized nicotine device solutions.

Inspire Technology Company's Co-CEO Michael Wang stated, "By combining our collective expertise in hardware, blockchain, and regulatory consulting, our goal is to set new standards for age verification, safety, and overall quality in the e-cigarette industry. We hope this joint venture will bring significant advancements in device control, safety, anti-counterfeiting, and enhanced user experience, ultimately improving overall market and consumer satisfaction."

References:

[1] Ispire, Berify and Chemular to Propel Innovation in Vape Hardware Manufacturing Industry

Also Read:

[1] ISPIRE Reports Strong Growth in Q2 FY2024: Operating Expenses Surge to $10.3 Million, Net Loss at $4 Million

[2] Joint Venture Between Ispire and Berify for PMTA and Software Development

#North America #United States #Open system e-cigarettes #Technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Subsidiary Warns of Surge in Illegal Nicotine Pouches in Canada, Calls for Unified Regulatory Framework

Imperial Tobacco Canada, a subsidiary of British American Tobacco, has urged the federal government to respond to the spread of illegal nicotine pouches by allowing approved products to be sold through a wider range of adult retail channels. The company is also calling for stronger retail inspections, enhanced digital tracking, and closer coordination among provinces to build a consistent regulatory framework and restore the accessibility of the legal market.

Dec.05 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Ukraine Military Voices Concern Over Potential Vape and Pouch Ban

Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.

Nov.10 by { "username": "", "position": "", "avatar": "", "auth": "", "seo_url": "" }

Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%

Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.